by Becker's Payer | Mar 11, 2026 | CMS, Industry News, Medicare Advantage
Elevance said it was “surprised and disappointed” by a recent CMS sanction threat, which would suspend enrollment in Medicare Advantage prescription drug plans, CFO Mark Kaye said March 10 at the Barclays 28th Annual Global Healthcare Conference in Miami. The...
by CNBC News | Mar 9, 2026 | Industry News, Medicare
Although Obamacare sign-ups have fallen significantly this year over skyrocketing monthly premiums, Dr. Mehmet Oz believes enrollment is still too high. Oz, the Trump administration’s top official overseeing the Affordable Care Act, told NBC News that millions of...
by JD Supra | Mar 9, 2026 | Industry News, Medicaid, Medicare
Key Takeaways: Centers for Medicare & Medicaid Services (CMS) deferred $259.5 million in federal Medicaid funds to Minnesota over program integrity concerns. CMS will impose a six-month nationwide moratorium on new enrollments for certain Durable Medical...
by Agent & Advisor | Mar 9, 2026 | A&A, Health, Industry News, Life Insurance, Protection/Income, Wealth
Indexed universal life (IUL) and fixed indexed annuities (FIAs) have traveled a long road. What started as niche products built to balance safety with growth potential has now matured into one of the most-watched segments in insurance, as market-linked gains, downside...
by KFF | Mar 3, 2026 | Industry News, Medicare, Part D
For people with Medicare, the Medicare Part D outpatient prescription drug benefit is provided by private plans, either Medicare Advantage plans that offer Part D drug coverage (MA-PDs) or, for those in traditional Medicare, stand-alone prescription drug plans (PDPs)....
by Agent & Advisor | Mar 2, 2026 | A&A, Industry News
Indexed universal life (IUL) insurance has surged in popularity over the past decade, but regulators warn that the way these products are illustrated often sets clients up with unrealistic expectations. For years, regulators, actuaries, and consumer advocates have...
